Wednesday, November 30, 2022
11/30/2022
ABSTRACT Cardiac myosin binding protein-C (cMyBP-C) is an essential regulator of heart function that is necessary for normal systolic and diastolic heart function and for enhanced contractility in response to inotropic agonists that phosphorylate cMyBP-C through numerous signaling pathways. Whereas phosphorylation is associated with cardiac protection, hypo-phosphorylation is consistently found in heart failure. Mutations in MYBPC3, the gene encoding cMyBP-C, are also the most common cause of hypertrophic cardiomyopathy (HCM), a disease with a prevalence of ~1:500. However, despite its significance to cardiac health and disease, there is still remarkably little known regarding how cMyBP-C mediates its functional effects or how cMyBP-C phosphorylation increases cardiac contractility in response to inotropic stimuli. Work from our 3 labs has shown unequivocally that cMyBP-C directly activates the thin filament in muscle sarcomeres in the same way as myosin cross-bridges. Our data thus demonstrate cMyBP-C effects to augment contraction or delay relaxation are due to direct effects of cMyBP-C to shift tropomyosin to an activated state on the thin filament. Here we take advantage of the revolution in cryo-EM to reveal detailed structures of cMyBP-C interactions with the thin filament and also with myosin-S1 for the first time. We will use cryo-EM reconstructions to identify key residues that mediate interactions with thin filaments and myosin-S1 and will test model predictions using an arsenal of functional approaches including a novel (“Spy-C”) method developed exclusively in our labs that allow us to replace the N'-terminal domains of cMyBP-C in sarcomeres in situ. Using our structural maps, we demonstrate proof of principle by identifying amino acids responsible for cMyBP-C activation of tropomyosin and show that phosphorylation causes cMyBP-C domains to reposition on the thin filament. Specific aims will build on these discoveries and combine our unique resources to: 1) Determine how individual cMyBP-C domains communicate with neighboring domains when bound to the thin filament and myosin-S1, and 2) Define how Ca2+ and phosphorylation modulate key regulatory interactions of cMyBP-C with the thin filament and myosin- S1. By identifying the critical molecular interactions that control cMyBP-C binding to the thin filament and myosin-S1 these studies will pave the way for future targeted approaches to modulate cardiac contraction and relaxation.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
